Thank you! Welcome to Cambridge Biocapital.
Oops! Something went wrong while submitting the form. Make sure you submit a valid email.
Cambridge Biocapital is the independent weekly newsletter covering business, funding and science news in the world-leading British biotech & VC ecosystem.
The United Kingdom biotech hub is one of the fastest growing and most rapidly changing ecosystems in the world. More than a third of all European biotech startups are established in Britain and have raised more venture capital and IPO funding than other biotech startups across Europe.
Keeping up with such dynamic scene is challenging and, until now, there was not a go-to publication for those interested in the field, from scientists to investors and entrepreneurs.
Cambridge Biocapital is more than just a newsletter. It is a manually curated, fully-fledged publication that aims to contribute to the ecosystem clarifying the biotech dealflow and highlighting interesting opportunities. It has a particular focus on the Cambridge area, as well as London and Oxford, due to their relative importance for the country's hub.
Cambridge Biocapital is a weekly publication covering the British biotech and VC ecosystem, with a focus on Cambridge, Oxford, and London.
The newsletter is sent out to subscribers on Friday morning and only requires 10 to 15 minutes of reading. Each Cambridge Biocapital issue encompasses start-up funding news and major scientific discoveries, updates from investment funds and accelerators, collaboration agreements, M&A activity, as well as key operations from big pharma players.
Cambridge Biocapital features weekly updates from the pharmaceutical industry and publicly traded companies in the biotech space.
The coverage has a focus on companies operating in UK and those whose activities might have an impact on British biotech ecosystem in terms of commercial strategic, collaboration deals, acquisitions and intellectual property. The section Pharma Affairs is also an opportunity to look across the pond and learn about the thriving US ecosystem.
Biotech space benefits from curious minds seeking to broaden and deepen their understanding of the world. Each newsletter issue recommends several podcasts and readings, such as investment thesis, scientific publications, or interviews.
Each issue features a project beyond biotech, such as art exhibitions or charitable initiatives, and a song which then becomes part of the Biocapital Sound playlist.
